Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:161-168

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunt, S. C.
Right arrow Articles by Williams, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunt, S. C.
Right arrow Articles by Williams, R. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Genes and Gene Therapy
Hazardous Substances DB
*POTASSIUM

Hypertension, Vol 22, 161-168, Copyright © 1993 by American Heart Association


ARTICLES

A gene-environment interaction between inferred kallikrein genotype and potassium

SC Hunt, SJ Hasstedt, LL Wu and RR Williams
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

Urinary kallikrein excretion has been shown statistically to be partially determined by a major gene in large Utah pedigrees with the use of segregation analysis. A previous twin analysis of environmental factors influencing urinary kallikrein level showed that urinary potassium twin differences were strongly related to differences in urinary kallikrein. The present study uses 769 individuals in 58 Utah pedigrees to analyze the association of urinary potassium with urinary kallikrein within statistically inferred kallikrein genotypes. Fitting genotype-specific curves relating urinary kallikrein level to 12-hour urinary potassium amount within a major gene, polygene, and common environment model, we showed a significant statistical urinary potassium interaction with the inferred major gene for kallikrein (P = .0002). The heterozygotes (with a frequency of 50%) had a significant association between urinary kallikrein and potassium (slope, 0.51 +/- 0.04 SD), whereas there was no association with potassium in the low homozygotes, suggesting a genetic defect involving the kallikrein response to potassium. The model predicted that an increase in urinary potassium excretion of 0.8 SD above the mean in these pedigrees would be associated with high kallikrein levels in the heterozygotes similar to the high homozygotes. A decrease of 1.3 SD in urinary potassium excretion in heterozygous individuals was associated with kallikrein levels similar to the homozygous individuals with low kallikrein. Because in the steady state urinary potassium represents dietary potassium intake, this study suggests that an increase in dietary potassium intake in 50% of these pedigree members, estimated to be heterozygous at the kallikrein locus, would be associated with an increase in an underlying genetically determined low kallikrein level.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Meneton, J. Loffing, and D. G. Warnock
Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F593 - F601.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al.
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
PNAS, February 15, 2001; (2001) 51619598.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Jin, L. Chao, and J. Chao
Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR
Am J Physiol Renal Physiol, March 1, 1999; 276(3): F476 - F484.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Hunt, L. L. Wu, P. N. Hopkins, and R. R. Williams
Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 912 - 917.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al.
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
PNAS, February 27, 2001; 98(5): 2634 - 2639.
[Abstract] [Full Text] [PDF]